必可酮气雾剂
- 网络Becotide;BDP
必可酮气雾剂-
目的评价吸入必可酮气雾剂（BDP）对咳嗽变异型哮喘（CVA）的疗效。
Objective To evaluate the effects of inhaled BDP in patients with CVA .
-
SD大鼠腹腔注射卵蛋白制成哮喘模型，分别予相应方法治疗，并与必可酮气雾剂比较。
SD rats were modeled into asthmatic rats by abdominal injection of egg albumin , and then treated by aforementioned methods ;
-
吸入激素组在常规治疗基础上，加用二丙酸倍氯米松（必可酮）气雾剂治疗，每天1000μg，连续治疗3个月；
Group A ( 24 cases ) inhaled glucocorticosteroids ( Becotide ( 1 000 μ g · d ~ ( - 1 )) for three months ) on the base of routine therapy .